Drooid Logo
Back to today’s briefing

Story perspectives

Fosun and Leo Launch Game-Changing Cancer Treatment in China

11/7/2025

34 4

1 of 2

Fosun Enhances Cancer Care
  • Fosun Pharmaceutical is collaborating with Leo Cancer Care to launch advanced particle therapy systems in mainland China, enhancing cancer treatment accessibility.
  • This partnership aligns with Beijing's objective to improve healthcare services.
  • Leo Cancer Care recently received FDA approval for its Marie medical facilities, which prioritize patient comfort and advanced technology.
  • CEO Stephen Towe noted that the Marie system could cut treatment costs by 50% and is 20 times smaller than conventional radiation technology.
  • This development represents a significant advancement in China's cancer care industry.
1 / 2